𧬠ICD-10 CM G35.B2 β Non-Active Primary Progressive Multiple Sclerosis
Billable Code Confirmed
ICD-10-CM G35.B2 is a valid, billable 5-character ICD-10-CM code for FY2026. The first three characters (G35) define the category of Multiple Sclerosis, the fourth character (B) specifies Primary progressive multiple sclerosis, and the fifth character (2) defines the specific activity status as non-active. No additional characters are required.
Non-Billable Parent Codes β Never Submit These
- β
G35β 3-character header β Lacks phenotype specificity (retired as a valid primary diagnosis as of FY2026).- β
G35.Bβ 4-character header β Lacks activity status specificity.Always submit G35.B2 (all 5 characters) when primary progressive multiple sclerosis is clinically documented without evidence of inflammatory disease activity.
Clinical Context: Phenotype and Activity Status
ICD-10 CM G35.B2 captures primary progressive multiple sclerosis (PPMS) during a period where there is no clinical or MRI evidence of new inflammatory activity (non-active). This specificity matters because it distinguishes the stable or purely neurodegenerative phase of PPMS from periods with active relapses or new lesions, which drives different treatment protocols and accurate documentation.
Code Classification
ICD-10-CM Diagnosis Code β wRVU, assistant payable, and global period fields are not applicable; direct reader to Commonly Associated CPT Codes and ICD-10-PCS Crosswalk sections for procedural alignments.
π Code Description
ICD-10 CM G35.B2 classifies non-active primary progressive multiple sclerosis. This code represents patients with a baseline progressive disease course from onset (primary progressive) who are currently not exhibiting signs of active central nervous system inflammation, such as new or enlarging T2 lesions on MRI or acute clinical relapses.
Multiple sclerosis is characterized by the autoimmune-mediated destruction of myelin in the central nervous system. In primary progressive MS, patients experience a steady decline in physical and cognitive function rather than the distinct attacks seen in relapsing-remitting forms. Accurate code selection requires clinical documentation confirming both the PPMS phenotype and the lack of current inflammatory activity.
π³ Code Tree / Hierarchy
G35 Multiple sclerosis β Non-billable
β
βββ G35.A Relapsing-remitting multiple sclerosis β
Billable
βββ G35.B Primary progressive multiple sclerosis β Non-billable
β β
β βββ G35.B0 Primary progressive multiple sclerosis, unspecified β
Billable
β βββ G35.B1 Active primary progressive multiple sclerosis β
Billable
β βββ G35.B2 Non-active primary progressive multiple sclerosis β THIS CODE β
Billable
β
βββ G35.C Secondary progressive multiple sclerosis β Non-billable
β β
β βββ G35.C0 Secondary progressive multiple sclerosis, unspecified β
Billable
β βββ G35.C1 Active secondary progressive multiple sclerosis β
Billable
β βββ G35.C2 Non-active secondary progressive multiple sclerosis β
Billable
β
βββ G35.D Multiple sclerosis, unspecified β
Billable
Phenotype Specificity Coding Insight
For FY2026, blanket coding of MS under the old
G35code will lead to claim denials or delays. You must query the provider if the medical record identifies βMultiple Sclerosisβ without specifying the phenotype (relapsing-remitting vs. progressive) and the activity level (active vs. non-active).
β Includes
The following clinical terms and scenarios map to G35.B2 when documented:
- Primary progressive multiple sclerosis without evidence of inflammatory disease activity
- Non-active primary progressive MS
β Excludes
Excludes 1 β Cannot Be Coded Simultaneously with G35.B2
| Code | Description | Note |
|---|---|---|
| G36.0 | Neuromyelitis optica [Devic] | Clinically distinct demyelinating syndrome targeting optic nerves and spinal cord; mutually exclusive with MS. |
| G37.3 | Acute transverse myelitis in demyelinating disease of central nervous system | Demyelination restricted to the spinal cord; mutually exclusive when part of a separate demyelinating disease classification. |
Excludes 1 Violation Risk
A common error is attempting to code multiple distinct demyelinating syndromes simultaneously. If a patientβs diagnosis evolves from isolated transverse myelitis to confirmed primary progressive multiple sclerosis, code only the definitive MS code (G35.B2).
Excludes 2 β May Be Coded in Addition if Separately Present
| Code | Description | Note |
|---|---|---|
| N/A | No specific Excludes 2 notes apply directly to this subcategory. | N/A |
π Clinical Overview
Phenotype and Activity Distinction
Accurate capture relies on parsing the specific disease trajectory and recent imaging findings from the neurology notes.
| Feature | G35.B2 β Non-Active PPMS | G35.B1 β Active PPMS | G35.A β Relapsing-Remitting MS |
|---|---|---|---|
| Disease Onset | Gradual worsening from onset. | Gradual worsening from onset. | Distinct attacks with recovery periods. |
| Current Inflammatory Activity | No (Stable MRI, no acute relapse). | Yes (New/enlarging MRI lesions or acute relapse). | Varies; episodic flares. |
| Treatment Focus | Symptom management, physical therapy. | Disease-modifying therapies (DMTs), steroids. | Disease-modifying therapies (DMTs), steroids. |
CDI Query Trigger β Specificity Missing
If the provider documents βPPMSβ but does not indicate whether there is active inflammation or stability in recent MRIs, query for activity status to accurately select between G35.B1 and G35.B2. Defaulting to
G35.B0(unspecified) should be avoided when data is available.
Manifestations & Symptom Burden
Always code the documented manifestations to fully capture the patientβs complexity. Common manifestations for PPMS include:
- Mobility Impairments: Spasticity, muscle weakness, or ataxia.
- Sensory Disturbances: Paresthesias, numbness, or loss of sensation.
- Visual Deficits: Optic neuritis, visual loss, or extra-ocular movement disorders.
- Autonomic Dysfunction: Bladder dysfunction or bowel irregularities.
Coding Manifestations
π° HCC Risk Adjustment (CMS-HCC v28)
| Field | Detail |
|---|---|
| CMS-HCC Model Version | v28 (2024-2025 Implementation) |
| HCC Assignment | β Mapped β HCC 198 |
| HCC Category | HCC 198 β Multiple Sclerosis |
| RAF Coefficient | ~0.450 - 0.500 (varies by demographic/status) |
G35.B2 maps directly to an HCC and contributes to the RAF score.
Capture Annually
MS is a chronic, lifelong condition. Even though G35.B2 indicates a βnon-activeβ state of inflammation, the progressive nature of the disease persists. It must be captured at least once every calendar year during a face-to-face encounter to ensure accurate risk adjustment and care management funding.
π₯ DRG Assignment
MDC 01 β Diseases and Disorders of the Nervous System
| DRG | Title | Est. Relative Weight* |
|---|---|---|
| DRG 058 | MULTIPLE SCLEROSIS AND CEREBELLAR ATAXIA with MCC | ~1.50 - 1.80 |
| DRG 059 | MULTIPLE SCLEROSIS AND CEREBELLAR ATAXIA with CC | ~1.00 - 1.20 |
| DRG 060 | MULTIPLE SCLEROSIS AND CEREBELLAR ATAXIA without CC/MCC | ~0.70 - 0.90 |
Approximate. Verify against IPPS FY2026 Final Rule tables.
Sequencing and Complications
If admitted specifically for an exacerbation of MS manifestations (e.g., severe spasticity requiring inpatient management), G35.B2 is sequenced as principal. If admitted for a complication unrelated to MS (e.g., pneumonia), G35.B2 is sequenced secondarily. Note that if a patient with non-active PPMS develops acute activity, the code must be updated to an active code (e.g., G35.B1).
π Related ICD-10-CM Codes
Phenotype Variants
| Code | Description |
|---|---|
| G35.A | Relapsing-remitting multiple sclerosis |
| G35.B1 | Active primary progressive multiple sclerosis |
| G35.C2 | Non-active secondary progressive multiple sclerosis |
π οΈ Commonly Associated CPT Codes (Outpatient / Profee)
Outpatient Setting Context
Non-active PPMS patients frequently present for routine monitoring, symptom management, and physical rehabilitation evaluations.
| CPT Code | Description | Profee Coding Notes (Modifier 26) |
|---|---|---|
| 99214 | Office or other outpatient visit, established patient | Frequent E/M level for complex chronic monitoring. |
| 95860 | Needle electromyography, one extremity | Used for evaluating muscle weakness or spasticity. |
| 92081 | Visual field examination, limited | Routine monitoring of optic nerve function. |
| 97110 | Therapeutic procedure, 1 or more areas, each 15 minutes | Standard for physical therapy management of mobility loss. |
NCCI Bundling Considerations
- Standard E/M modifiers (e.g., Modifier -25) apply if a significant, separately identifiable evaluation and management service is provided on the same day as a minor procedural intervention (e.g., a spasticity injection).
π¬ ICD-10-PCS Crosswalk (Inpatient Procedures)
When G35.B2 is an inpatient diagnosis, these PCS codes are relevant for associated inpatient interventions, typically targeting severe symptomatic manifestations.
| PCS Section | Body System | Root Operation | Clinical Application |
|---|---|---|---|
| 0 (Medical and Surgical) | W (Anatomical Regions, General) | 3 (Control) | Placement of a percutaneous feeding tube (e.g., 0WJG3ZZ) if severe dysphagia develops. |
| F (Physical Rehabilitation) | 0 (Rehabilitation) | 9 (Assessments) | Physical therapy assessment of motor/nerve function (e.g., F01Z4EZ). |
π Coding Scenarios and Examples
Scenario 1 β Outpatient Neurology: Routine Follow-Up
Clinical Vignette: A 48-year-old female presents for a routine 6-month follow-up of her primary progressive multiple sclerosis. She reports a slow but steady decline in her walking distance over the past year. Recent brain and cervical spine MRIs show stable demyelinating plaques with no gadolinium-enhancing lesions. Her neurologist assesses her as stable without current inflammatory activity and adjusts her physical therapy orders.
CPT / HCPCS (Profee):
- 99214 β Office/outpatient visit, established patient, moderate MDM.
ICD-10-CM:
- G35.B2 β Non-active primary progressive multiple sclerosis (Correctly captures the PPMS phenotype and the lack of new inflammatory disease activity shown on MRI).
Scenario 2 β Inpatient: Secondary Diagnosis for UTI
Clinical Vignette: A 55-year-old male with a history of non-active primary progressive multiple sclerosis and a neurogenic bladder is admitted for a severe catheter-associated urinary tract infection (CAUTI) causing sepsis.
Principal Diagnosis:
- A41.9 β Sepsis, unspecified organism (Reason for admission)
Secondary Diagnoses:
- T83.511A β Infection and inflammatory reaction due to indwelling urethral catheter, initial encounter
- N39.0 β Urinary tract infection, site not specified
- G35.B2 β Non-active primary progressive multiple sclerosis (Systemic comorbidity influencing patient care and baseline risk).
- N31.9 β Neuromuscular dysfunction of bladder, unspecified
MS-DRG Assignment: The presence of Sepsis acts as the principal diagnosis grouping to MDC 18. G35.B2 acts as a chronic comorbidity that supports the medical necessity of the complex admission but does not function as a CC/MCC for the Sepsis DRG grouping on its own.
Scenario 3 β CDI Query: Missing Activity Status
Clinical Vignette: The providerβs discharge summary states: βPatient admitted for management of severe spasticity secondary to Primary Progressive Multiple Sclerosis. The patient had a brain MRI performed yesterday which was reviewed and showed no changes from baseline.β
Action / Outcome: The documentation lacks explicit confirmation of the diseaseβs βactivityβ status, although the βno changes from baselineβ MRI strongly implies a non-active state. A CDI query should be placed to clarify the specific activity status of the PPMS for accurate code assignment.
Query Response: Provider updates documentation to state: βPrimary Progressive Multiple Sclerosis, non-active based on stable MRI.β
Corrected ICD-10-CM Coding:
- G35.B2 β Non-active primary progressive multiple sclerosis.
β οΈ Coding Pitfalls and Tips
| Pitfall or Tip | |
|---|---|
| β | Using the retired 3-character header. Defaulting to the historical G35 code for dates of service after October 1, 2025, will result in immediate claim denials. You must code to the 4th or 5th character. |
| β | Assuming βunspecifiedβ when data exists. Do not default to G35.B0 (Primary progressive MS, unspecified) if the medical record contains clear language or MRI findings that confirm active or non-active status. Query if ambiguous. |
| β | Code all manifestations. Always capture secondary codes for specific symptoms (e.g., neurogenic bladder, ataxia, paraplegia) to thoroughly paint the picture of the patientβs severity of illness and risk of mortality. |
| β | Annual HCC capture. Ensure G35.B2 is documented and billed at least once a year during a face-to-face encounter to support risk-adjusted funding for the patientβs chronic condition. |
Crystal's Coder Hub